ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]
Rapid detection of Candida species in bronchoalveolar lavage fluid from patients with pulmonary symptoms.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Suspected allergic bronchopulmonary candidiasis in a patient with concurrent multidrug-resistant bacterial pneumonia: A case report.Medicine · 2026Article
- Molecular identification and phylogenetic analysis of yeast strains isolated from dairy products in Isfahan, Iran.Iranian journal of microbiology · 2025Article
- Analysis of microorganisms and drug-resistance mutations detected by probe-capture metagenomics among HIV-infected patients with pneumonia.Frontiers in microbiology · 2025Article
- Synergistic effects ofFrontiers in cellular and infection microbiology · 2025Article
- Identification and assessment of antifungal susceptibility ofIranian journal of microbiology · 2024Article
- Antifungal activity of three different varieties of Capsicum annuum against clinical isolates of Candida species.Tropical diseases, travel medicine and vaccines · 2023Article
- Diagnostic Value of Metagenomic Next-Generation Sequencing for Multi-Pathogenic Pneumonia in HIV-Infected Patients.Infection and drug resistance · 2023Article
- Allergic bronchopulmonary candidiasis: A review of the literature and a case report.BMC pulmonary medicine · 2022Review
- Article
- Deep Fungal Infections Among General Hospital Inpatients in Southwestern China: A 5-Year Retrospective Study.Frontiers in public health · 2022Article
- Expression of anti-fungal peptide, β-defensin 118 in oral fibroblasts induced by C. albicans β-glucan-containing particles.Journal of applied oral science : revista FOB · 2022Article
- Recombinant polymerase amplification combined with lateral flow strips for the detection of deep-seatedFrontiers in cellular and infection microbiology · 2022Article
- Time to Positivity Facilitates an Early Differential Diagnosis ofInfection and drug resistance · 2022Article
- Antifungal Activity of Curcuminoids and Difluorinated Curcumin Against Clinical Isolates of Candida Species.Advances in experimental medicine and biology · 2021Article
- Case Report: Next-Generation Sequencing in Diagnosis of Pneumonia Due toFrontiers in medicine · 2021Article
- Low prevalence of antifungal resistantHeliyon · 2020Article
- UPLC-MS-ESI-QTOF Analysis and Antifungal Activity of theAntibiotics (Basel, Switzerland) · 2019Article
- Identification ofPathogens (Basel, Switzerland) · 2019Article
- Kinetics of antifungal activity of home-generated ozonated water onCurrent medical mycology · 2018Article
- High prevalence of candiduria due to non-albicans Candida species among diabetic patients: A matter of concern?Journal of clinical laboratory analysis · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Candida species, especially C. albicans, are commensals on human mucosal surfaces, but are increasingly becoming one of the important invasive pathogens as seen by a rise in its prevalence in immunocompromised patients and in antibiotic consumption. Thus, an accurate identification of Candida species in patients with pulmonary symptoms can provide important information for effective treatment. A total of 75 clinical isolates of Candida species were obtained from the bronchoalveolar lavage fluid of both immunocompromised and immunocompetent patients with pulmonary symptoms. Candida cultures were identified based on nuclear ribosomal Internal Transcribed Spacer (ITS1-ITS2 rDNA) sequence analysis by polymerase chain reaction-restriction fragment length polymorphisms (PCR-RFLP). Molecular identification indicated that the isolates belonged predominantly to C. albicans (52%), followed by C. tropicalis (24%), C. glabrata (14.7%), C. krusei (5.3%), C. parapsilosis (1.3%), C. kefyr (1.3%) and C. guilliermondii (1.3%). Given the increasing complexity of disease profiles and their management regimens in diverse patients, rapid and accurate identification of Candida species can lead to timely and appropriate antifungal therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.